Bruce Parsons

TL;DR: Evaluated weight effects in patients receiving standard doses of amisulpride, haloperidol, olanzapine, risperidone, ziprasid one, and placebo confirm significant differences in long-term weight effects among atypical antipsychotics, consistent with findings from prior meta-analysis of antipsychotic-induced weight gain.

TL;DR: Pregabalin treatment resulted in statistically significant improvements over placebo for all primary and key secondary outcome measures and demonstrates that pregabalin is effective and well tolerated in patients with neuropathic pain due to SCI.

TL;DR: Outcomes related to pain interference with function, sleep, health status, activity impairment, prescription medication use, and direct and indirect costs were significantly worse among subjects with more severe pain (P < 0.0020).

TL;DR: PTPS NeP subjects reported high pain scores, which were associated with poor health utility, sleep, mood, and function, as well as high health care resource utilization and costs, and an unmet need for effective and comprehensive management.

TL;DR: This is the first study to provide an estimate of the prevalence of probable NeP in the US, showing significant variation by age and ethnicity.